keyword
https://read.qxmd.com/read/38656126/increased-virtual-visits-to-physicians-during-the-covid-19-pandemic-and-estimated-impact-on-physician-compensation-the-case-of-lung-and-colorectal-cancers-chronic-obstructive-pulmonary-diseases-and-heart-failure-in-alberta-canada
#1
JOURNAL ARTICLE
Nguyen Xuan Thanh, Arianna Waye, Douglas Stewart, Jason Weatherald, Grace Y Lam, Michael K Stickland, Michael D Hill, Jonathan Choy, Anderson W Chuck, Tracy Wasylak
Introduction: The COVID-19 pandemic started in Alberta in March 2020 and significantly increased telehealth service use and provision reducing the risk of virus transmission. We examined the change in the number and proportion of virtual visits by physician specialty and condition (chronic obstructive pulmonary diseases [COPD], heart failure [HF], colorectal and lung cancers), as well as associated changes in physician compensation. Methods: A population-based design was used to analyze all processed physician claims comparing the number and proportion of virtual visits and associated physician billings relative to in-person between pre- (2019/2020) and intra-pandemic (2020/2021)...
April 24, 2024: Telemedicine Journal and E-health
https://read.qxmd.com/read/38654044/genomic-landscape-of-diploid-and-aneuploid-microsatellite-stable-early-onset-colorectal-cancer
#2
JOURNAL ARTICLE
Yumei Zhou, Xianfeng Chen, Jun Chen, Conner D Kendrick, Ramesh K Ramanathan, Rondell P Graham, Kimberlee F Kossick, Lisa A Boardman, Michael T Barrett
Although colorectal cancer (CRC) remains the second leading cause of cancer-related death in the United States, the overall incidence and mortality from the disease have declined in recent decades. In contrast, there has been a steady increase in the incidence of CRC in individuals under 50 years of age. Hereditary syndromes contribute disproportionately to early onset CRC (EOCRC). These include microsatellite instability high (MSI+) tumors arising in patients with Lynch Syndrome. However, most EOCRCs are not associated with familial syndromes or MSI+ genotypes...
April 23, 2024: Scientific Reports
https://read.qxmd.com/read/38653930/robotic-resection-of-presacral-tumors
#3
JOURNAL ARTICLE
D Ferrari, T Violante, P Addison, W R G Perry, A Merchea, S R Kelley, K L Mathis, E J Dozois, D W Larson
BACKGROUND: Presacral tumors are a rare entity typically treated with an open surgical approach. A limited number of minimally invasive resections have been described. The aim of the study is to evaluate the safety and efficacy of roboticresection of presacral tumors. METHODS: This is a retrospective single system analysis, conducted at a quaternary referral academic healthcare system, and included all patients who underwent a robotic excision of a presacral tumor between 2015 and 2023...
April 23, 2024: Techniques in Coloproctology
https://read.qxmd.com/read/38653496/safety-and-efficacy-of-a-novel-miniaturized-robotic-assisted-surgery-system-in-colectomy-a-prospective-investigational-device-exemption-clinical-study-using-the-ideal-framework
#4
JOURNAL ARTICLE
John H Marks, Deborah S Keller, Jorge A Lagares-Garcia, Henry P Schoonyoung, Shane M Farritor, Dmitry Oleynikov, Michael A Jobst
BACKGROUND: Robotics has increased rates of minimally invasive surgery, with distinct advantages over open surgery. However, current commercially available robotic platforms have device and system issues that limit robot-assisted surgery expansion. OBJECTIVE: To demonstrate the safety and efficacy of a novel miniaturized robotic assisted surgery device in colectomy. DESIGN: Prospective, Investigational Device Exemption clinical study following the idea, development, exploration, assessment, and long-term follow-up (IDEAL) framework (Stage 2b, exploration)...
April 23, 2024: Diseases of the Colon and Rectum
https://read.qxmd.com/read/38653495/transitional-care-in-patients-with-hirschsprung-disease-those-left-behind
#5
JOURNAL ARTICLE
David S Thompson, Joseph R Davidson, Kathryne Ford, Stavros Loukogeorgakis, Simon Eaton, Simon Blackburn, Joseph Curry
BACKGROUND: The long term effects of Hirschsprung disease are clinically variable. Improved understanding of challenges patients may face as adults can help inform transitional care management. OBJECTIVE: To explore the outcomes and transitional care experiences in adult patients with Hirschsprung. DESIGN: Cohort study. SETTING: Single center. PATIENTS: All patients treated for Hirschsprung 1977-2001 (aged >18 at time of survey July 2018-2019)...
April 23, 2024: Diseases of the Colon and Rectum
https://read.qxmd.com/read/38653494/segmental-colectomy-in-ulcerative-colitis
#6
JOURNAL ARTICLE
Sumeyye Yilmaz, Rebecca L Gunter, Arielle E Kanters, David R Rosen, Jeremy Lipman, Stefan D Holubar, Tracy L Hull, Scott R Steele
BACKGROUND: Segmental colectomy in ulcerative colitis is performed in select patients who may be at increased risk for postoperative morbidity. OBJECTIVE: To identify ulcerative colitis patients who underwent segmental colectomy and assess their postoperative and long-term outcomes. DESIGN: Retrospective case series. SETTING: A tertiary-care inflammatory bowel disease center. PATIENTS: Ulcerative colitis patients who underwent surgery between 1995 and 2022...
April 23, 2024: Diseases of the Colon and Rectum
https://read.qxmd.com/read/38653493/cytological-analysis-of-the-surgical-field-during-transanal-total-mesorectal-excision-for-rectal-cancer-a-prospective-study
#7
JOURNAL ARTICLE
Yushi Suzuki, Hiro Hasegawa, Takashi Mori, Koichi Teramura, Yuichiro Tsukada, Takeshi Sasaki, Motohiro Kojima, Masaaki Ito
BACKGROUND: An unexpectedly large number of patients experienced local recurrence with transanal total mesorectal excision in Norway. This appears to be associated with cancer cell spillage during surgery. OBJECTIVE: To investigate the surgical field cytology during transanal total mesorectal excision. DESIGN: This was a prospective cohort study. SETTINGS: This study was conducted at a single center between June and December 2020...
April 23, 2024: Diseases of the Colon and Rectum
https://read.qxmd.com/read/38653492/rectovaginal-fistula-what-is-the-role-of-martius-flap-and-gracilis-muscle-interposition-in-the-therapeutic-strategy
#8
JOURNAL ARTICLE
Clément Pastier, Jérôme Loriau, Quentin Denost, Lauren O'Connell, Alexandre Challine, Maxime Collard, Clotilde Debove, Najim Chafai, Yann Parc, Jérémie H Lefevre
BACKGROUND: While numerous treatments exist for management of rectovaginal fistula, none has demonstrated its superiority. The role of diverting stoma remains controversial. Few series include Martius flap in the armamentarium. OBJECTIVE: Determine the role of gracilis muscle interposition and Martius flap in the surgical management of rectovaginal fistula. DESIGN: Retrospective cohort study of a pooled prospectively maintained database from 3 centers...
April 23, 2024: Diseases of the Colon and Rectum
https://read.qxmd.com/read/38652519/prophylactic-biosynthetic-retrorectus-mesh-placement-during-stoma-reversal-reduces-the-rate-of-stoma-site-incisional-hernia
#9
JOURNAL ARTICLE
Brandon K Vu, Jessica Lam, Matthew J Sherman, Michael S Tam
INTRODUCTION: Stoma site incisional hernias (SSIHs) are associated with substantial long-term morbidity, and the rate can be as high as 30% to 40%. Recent efforts using prophylactic mesh reinforcement (PMR) to reduce the development of hernias have shown encouraging outcomes. The objective of this study was to assess the use of prophylactic biosynthetic mesh at the time of stoma reversal on the overall SSIH rate. METHODS: This is an observational retrospective cohort study...
April 23, 2024: Permanente Journal
https://read.qxmd.com/read/38652334/analysis-of-trajectory-changes-and-predictive-factors-of-sense-of-coherence-in-patients-after-colorectal-cancer-surgery
#10
JOURNAL ARTICLE
Jie Chen, Nanxiao Ren, Aifeng Meng, Tiantian Wang, Yamei Bai, Ying Xu, Xiaoli Li, Xiaoxu Zhi
OBJECTIVE: To investigate the trajectories and potential categories of changes in the sense of coherence (SOC) in patients after colorectal cancer surgery and to analyze predictive factors. METHODS: From January to July 2023, 175 patients with colorectal cancer treated at a tertiary Grade A oncology hospital in Jiangsu Province were selected as the study subjects. Prior to surgery, SOC-13 scale, Patient-Generated Subjective Global Assessment (PG-SGA), Brief Illness Perception Questionnaire (BIPQ), and Social Support Rating Scale (SSRS) were used to survey the patients...
April 23, 2024: Supportive Care in Cancer
https://read.qxmd.com/read/38652261/predicting-prognosis-and-immunotherapy-response-in-colorectal-cancer-by-pericytes-insights-from-single-cell-rna-sequencing
#11
JOURNAL ARTICLE
Chen Wei, Weikai Wang, Zhihao Hu, Zhuoli Huang, Ye Lu, Wenwen Zhou, Xiaoying Liu, Xin Jin, Jianhua Yin, Guibo Li
Immunotherapy has revolutionized the treatment of tumors, but there are still a large number of patients who do not benefit from immunotherapy. Pericytes play an important role in remodeling the immune microenvironment. However, how pericytes affect the prognosis and treatment resistance of tumors is still unknown. This study jointly analyzed single-cell RNA sequencing (scRNA-seq) data and bulk RNA sequencing data of multiple cancers to reveal pericyte function in the colorectal cancer microenvironment. Analyzing over 800 000 cells, it was found that colorectal cancer had more pericyte enrichment in tumor tissues than other cancers...
April 23, 2024: Human Molecular Genetics
https://read.qxmd.com/read/38650948/short-chain-fatty-acids-induced-lung-tumor-cell-death-and-increased-peripheral-blood-cd4-t-cells-in-nsclc-and-control-patients-ex-vivo
#12
JOURNAL ARTICLE
Carolin D Thome, Patrick Tausche, Katja Hohenberger, Zuqin Yang, Susanne Krammer, Denis I Trufa, Horia Sirbu, Joachim Schmidt, Susetta Finotto
BACKGROUND: Despite therapy advances, one of the leading causes of cancer deaths still remains lung cancer. To improve current treatments or prevent non-small cell lung cancer (NSCLC), the role of the nutrition in cancer onset and progression needs to be understood in more detail. While in colorectal cancer, the influence of local microbiota derived SCFAs have been well investigated, the influence of SCFA on lung cancer cells via peripheral blood immune system should be investigated more deeply...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650801/the-association-of-the-epidermal-growth-factor-receptor-egfr-immunoexpression-with-prognostic-parameters-in-adenocarcinoma-patients-receiving-neoadjuvant-treatment
#13
JOURNAL ARTICLE
Derya Demir, Murtaza Parvizi, Burcin Pehlivanoglu, Erhan Ergin, Semin Ayhan, Basak Doganavsargil
The epidermal growth factor receptor (EGFR) expression is considered to play an essential role in the pathogenesis of colorectal adenocarcinoma. This study assessed the expression and predictive/prognostic value of EGFR expression in pre-op biopsy and post-op resection specimens in patients receiving neoadjuvant radiotherapy/neoadjuvant chemoradiotherapy (NRT/NCRT). Thirty-four consecutive patients were included in this study. The association between the prognostic features and EGFR immunohistochemical expression was analyzed in pre- (n=34) and post-treatment (n=22) tissue samples in cases with available tissue blocks...
March 2024: Curēus
https://read.qxmd.com/read/38650006/predictive-significance-of-fgfr4-p-g388r-polymorphism-in-metastatic-colorectal-cancer-patients-receiving-trifluridine-tipiracil-tas-102-treatment
#14
JOURNAL ARTICLE
Alessandro Ottaiano, Mariachiara Santorsola, Monica Ianniello, Anna Ceccarelli, Marika Casillo, Francesco Sabbatino, Nadia Petrillo, Marco Cascella, Francesco Caraglia, Carmine Picone, Francesco Perri, Roberto Sirica, Silvia Zappavigna, Guglielmo Nasti, Giovanni Savarese, Michele Caraglia
BACKGROUND: TAS-102 (Lonsurf® ) is an oral fluoropyrimidine consisting of a combination of trifluridine (a thymidine analog) and tipiracil (a thymidine phosphorylation inhibitor). The drug is effective in metastatic colorectal cancer (mCRC) patients refractory to fluorouracil, irinotecan and oxaliplatin. This study is a real-world analysis, investigating the interplay of genotype/phenotype in relation to TAS-102 sensitivity. METHODS: Forty-seven consecutive mCRC patients were treated with TAS-102 at the National Cancer Institute of Naples from March 2019 to March 2021, at a dosage of 35 mg/m2 , twice a day, in cycles of 28 days (from day 1 to 5 and from day 8 to 12)...
April 22, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38649928/the-effect-of-colchicine-on-cancer-risk-in-patients-with-immune-mediated-inflammatory-diseases-a-time-dependent-study-based-on-the-taiwan-s-national-health-insurance-research-database
#15
JOURNAL ARTICLE
Jun-Jun Yeh, Pei-Xuan Liw, Yi-Sin Wong, Husan-Min Kao, Chia-Hsun Lee, Cheng-Li Lin, Chia-Hung Kao
BACKGROUND: To determine the effect of colchicine on cancer risk in patients with the immune-mediated inflammatory diseases (IMIDs)-related to colchicine use. METHODS: This is a time-dependent propensity-matched general population study based on the National Health Insurance Research Database (NHIRD) of Taiwan. We identified the IMIDs patients (n = 111,644) newly diagnosed between 2000 and 2012 based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)-274,712, 135, 136...
April 22, 2024: European Journal of Medical Research
https://read.qxmd.com/read/38649845/mafld-with-central-obesity-is-associated-with-increased-risk-of-colorectal-adenoma-and-high-risk-adenoma
#16
JOURNAL ARTICLE
Jingfang Xiong, Yijun Wu, Dongya Chen, Zhaolin Zhang, Yihui Liu, Jiandong Luo, Hong Xu
OBJECTIVE: To analyze the risk factors associated with colorectal adenoma and to investigate the associations of metabolism-related fatty liver disease (MAFLD) with obesity, colorectal adenoma and high-risk adenoma. METHODS: A total of 1395 subjects were enrolled and divided into a colorectal adenoma group (593 subjects) and a control group (802 subjects) according to the inclusion and exclusion criteria. The characteristics of patients in the colorectal adenoma group and the control group were compared by the chi-square test...
April 22, 2024: BMC Gastroenterology
https://read.qxmd.com/read/38649261/the-impact-of-potential-confounders-on-the-diagnostic-sensitivity-of-circulating-free-dna-in-management-of-fit-patients-a-pilot-study
#17
JOURNAL ARTICLE
Mauro Scimia, Francesco Pepe, Gianluca Russo, Lucia Palumbo, Umberto Malapelle, Rachel Chuang, Simone Scimia, Michael Sha, Hiromi Tanaka, Shuo Shen, David Chen, Giancarlo Troncone, Maria Antonia Bianco
Cell-free DNA (cfDNA) has long been established as a useful diagnostic and prognostic tool in a variety of clinical settings, ranging from infectious to cardiovascular and neoplastic diseases. However, non-neoplastic diseases can act as confounders impacting on the amount of cfDNA shed in bloodstream and on technical feasibility of tumour derived free circulating nucleic acids selecting patients with cancer. Here, we investigated the potential impact of other pathological processes in the clinical stratification of 637 FIT+ patients...
April 22, 2024: Journal of Clinical Pathology
https://read.qxmd.com/read/38648995/systematic-review-of-the-efficacy-of-stereotactic-ablative-radiotherapy-for-oligoprogressive-disease-in-metastatic-cancer
#18
REVIEW
Emma Doyle, Angus J Killean, Stephen Harrow, Iain D Phillips
BACKGROUND: Stereotactic Ablative Radiotherapy (SABR) for the treatment of oligometastatic disease can improve survival and delay the requirement for systemic therapy. The benefits of SABR in oligoprogressive disease are less well-defined. Here, we evaluate the available evidence investigating the efficacy of SABR in the treatment of oligoprogressive disease. METHODS: A systematic review was carried out following PRISMA guidelines. Medline and Embase databases were searched using the terms "stereotactic radiotherapy" OR "SABR" OR "Stereotactic Ablative Body Radiotherapy" OR "SBRT" OR "SRT" AND "oligoprogression" in May 2022, June 2023, and February 2024...
April 20, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/38648736/risk-prediction-of-post-endoscopic-submucosal-dissection-coagulation-syndrome
#19
JOURNAL ARTICLE
Minjee Kim, Chang Wan Choi, Eun Ran Kim, Dong Kyung Chang, Sung Noh Hong
INTRODUCTION: Endoscopic submucosal dissection (ESD) has been popular worldwide to treat laterally spreading tumors and large polyps. Post-ESD coagulation syndrome (PECS) is more common than the two major ESD-related complications, perforation and bleeding. The aim of this study was to assess the prevalence of PECS, identify the risk factors for PECS, and create a risk prediction model for PECS. METHODS: Retrospective cross-sectional study analyzed a total of 986 patients who underwent colorectal ESD...
April 22, 2024: Digestive Diseases
https://read.qxmd.com/read/38647857/adjuvant-chemotherapy-is-associated-with-better-oncological-outcomes-after-alpps-for-colorectal-liver-metastases
#20
JOURNAL ARTICLE
Fernando A Alvarez, Victoria Ardiles, Camila Chara, Martin de Santibañes, Rodrigo Sánchez Clariá, Juan Pekolj, Eduardo de Santibañes
ALPPS enables complete tumor resection in a shorter interval and a larger number of patients than classic two-stage hepatectomies. However, there is little evidence regarding long-term outcomes in patients with colorectal liver metastases (CLM). This study aims to evaluate the short and long-term outcomes of ALPPS in patients with CRM. Single-cohort, prospective, observational study. Patients with unresectable CLM due to insufficient liver remnant who underwent ALPPS between June 2011 and June 2021 were included...
April 22, 2024: Updates in Surgery
keyword
keyword
20617
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.